| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
69,860,000 |
| Market
Cap: |
40.64(M) |
| Last
Volume: |
53,038 |
Avg
Vol: |
52,611 |
| 52
Week Range: |
$0.4511 - $1.28 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Consumer Non-Durables |
| Level
III Sector: |
Personal Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.8 |
| Insider 3/6 Months : 7.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Veru is an oncology biopharmaceutical company with a focus on developing medicines for the management of breast and prostate cancers. Co.'s segments are: Research and Development and the Sexual Health Business. Co. has various drug products under clinical development. Activities related to these potential drug products are included in the Research and Development segment. Co.'s Sexual Health Business segment includes its C2 Female Condom® (Internal Condom) product for the protection against unintended pregnancy and sexually transmitted infections and a drug candidate, ENTADFI™ (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
150,000 |
150,000 |
165,711 |
| Total Buy Value |
$0 |
$84,351 |
$84,351 |
$106,047 |
| Total People Bought |
0 |
1 |
1 |
3 |
| Total Buy Transactions |
0 |
2 |
2 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
242,058 |
| Total Sell Value |
$0 |
$0 |
$0 |
$334,454 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
6 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rankowitz Michael L |
Director |
– • – |
2025-02-19 |
4 |
B |
$0.58 |
$31,919 |
D/D |
54,721 |
250,000 |
2.39 |
-3% |
|
| Rankowitz Michael L |
Director |
– • – |
2025-02-18 |
4 |
B |
$0.55 |
$52,432 |
D/D |
95,279 |
195,279 |
2.39 |
6% |
|
| Katzovitz Loren Mark |
Director |
– • – |
2024-08-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
224,000 |
|
-19% |
|
| Fisch Harry |
Chief Corporate Officer |
• • – |
2024-05-24 |
4 |
B |
$1.25 |
$5,000 |
D/D |
4,000 |
774,736 |
2.81 |
-37% |
|
| Barnette K Gary |
Chief Scientific Officer |
• – – |
2024-05-24 |
4 |
B |
$1.34 |
$6,697 |
D/D |
5,000 |
5,000 |
2.74 |
-37% |
|
| Steiner Mitchell Shuster |
President and CEO |
• • – |
2024-05-24 |
4 |
S |
$1.23 |
$78,102 |
D/D |
(63,379) |
6,942,709 |
|
37% |
|
| Steiner Mitchell Shuster |
President and CEO |
• • – |
2024-05-23 |
4 |
S |
$1.35 |
$405 |
D/D |
(300) |
7,006,088 |
|
41% |
|
| Steiner Mitchell Shuster |
President and CEO |
• • – |
2024-05-22 |
4 |
S |
$1.39 |
$9,018 |
D/D |
(6,504) |
7,006,388 |
|
45% |
|
| Steiner Mitchell Shuster |
President and CEO |
• • – |
2024-05-17 |
4 |
S |
$1.32 |
$36,988 |
D/D |
(28,066) |
7,012,892 |
|
41% |
|
| Steiner Mitchell Shuster |
President and CEO |
• • – |
2024-05-16 |
4 |
S |
$1.41 |
$84,128 |
D/D |
(59,788) |
7,040,958 |
|
43% |
|
| Steiner Mitchell Shuster |
President and CEO |
• • – |
2024-05-15 |
4 |
S |
$1.50 |
$125,813 |
D/D |
(84,021) |
7,100,746 |
|
47% |
|
| Fisch Harry |
Chief Corporate Officer |
• • – |
2024-05-15 |
4 |
B |
$1.49 |
$9,999 |
D/D |
6,711 |
770,736 |
2.81 |
-47% |
|
| Eisenberger Mario |
Director |
– • – |
2022-08-15 |
4 |
S |
$20.04 |
$2,003,550 |
D/D |
(100,000) |
0 |
|
75% |
|
| Eisenberger Mario |
Director |
– • – |
2022-08-15 |
4 |
OE |
$1.20 |
$156,950 |
D/D |
100,000 |
100,000 |
|
- |
|
| Lu Lucy |
Director |
– • – |
2021-08-17 |
4 |
B |
$6.78 |
$32,542 |
D/D |
4,800 |
9,800 |
2.39 |
- |
|
| Fisch Harry |
Director |
– • • |
2021-06-16 |
4 |
S |
$8.35 |
$835,300 |
D/D |
(100,000) |
764,025 |
|
- |
|
| Lu Lucy |
Director |
– • – |
2021-05-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| Hyun Grace |
Director |
– • – |
2021-03-10 |
4 |
B |
$14.09 |
$49,315 |
D/D |
3,500 |
14,790 |
2.39 |
- |
|
| Steiner Mitchell Shuster |
President and CEO |
• • • |
2021-02-12 |
4 |
S |
$20.88 |
$417,688 |
I/I |
(20,000) |
190,000 |
|
- |
|
| Steiner Mitchell Shuster |
President and CEO |
• • • |
2020-12-16 |
4 |
S |
$9.69 |
$2,421,625 |
D/D |
(250,000) |
7,184,767 |
|
- |
|
| Barnette K Gary |
Chief Scientific Officer |
• – – |
2020-12-16 |
4 |
S |
$10.65 |
$1,064,510 |
D/D |
(100,000) |
0 |
|
- |
|
| Fisch Harry |
Director |
– • • |
2020-08-26 |
4 |
B |
$2.76 |
$13,800 |
D/D |
5,000 |
864,025 |
3.92 |
- |
|
| Greco Michele |
CAO and CFO |
• – – |
2020-08-24 |
4 |
B |
$2.65 |
$13,233 |
D/D |
5,000 |
96,178 |
2.74 |
- |
|
| Hyun Grace |
Director |
– • – |
2020-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,290 |
|
- |
|
| Fisch Harry |
Director |
– • • |
2020-02-21 |
4 |
B |
$4.47 |
$4,470 |
D/D |
1,000 |
859,025 |
3.84 |
- |
|
184 Records found
|
|
Page 1 of 8 |
|
|
